Target engagement and immunogenicity of an active immunotherapeutic targeting pathological α-synuclein: a phase 1 placebo-controlled trial
针对病理性 α-突触核蛋白的主动免疫治疗的靶标参与和免疫原性：一项 1 期安慰剂对照试验
期刊:Nature Medicine
影响因子:58.7
doi:10.1038/s41591-024-03101-8
Pepijn Eijsvogel #, Pinaki Misra #, Luis Concha-Marambio, Justin D Boyd, Shuang Ding, Lauren Fedor, Yueh-Ting Hsieh, Yu Shuang Sun, Madeline M Vroom, Carly M Farris, Yihua Ma, Marieke L de Kam, Igor Radanovic, Maurits F J M Vissers, Dario Mirski, Ghazal Shareghi, Mohammad Shahnawaz, Wolfgang Singer,
